» Articles » PMID: 38353470

Targeting Type H Vessels in Bone-related Diseases

Overview
Journal J Cell Mol Med
Date 2024 Feb 14
PMID 38353470
Authors
Affiliations
Soon will be listed here.
Abstract

Blood vessels are essential for bone development and metabolism. Type H vessels in bone, named after their high expression of CD31 and Endomucin (Emcn), have recently been reported to locate mainly in the metaphysis, exhibit different molecular properties and couple osteogenesis and angiogenesis. A strong correlation between type H vessels and bone metabolism is now well-recognized. The crosstalk between type H vessels and osteoprogenitor cells is also involved in bone metabolism-related diseases such as osteoporosis, osteoarthritis, fracture healing and bone defects. Targeting the type H vessel formation may become a new approach for managing a variety of bone diseases. This review highlighted the roles of type H vessels in bone-related diseases and summarized the research attempts to develop targeted intervention, which will help us gain a better understanding of their potential value in clinical application.

Citing Articles

Progress in understanding Legg-Calvé-Perthes disease etiology from a molecular and cellular biology perspective.

Zheng X, Dong Z, Ding X, Huang Q, Tang S, Zhang Y Front Physiol. 2025; 16:1514302.

PMID: 40041162 PMC: 11876877. DOI: 10.3389/fphys.2025.1514302.


Mechanism of hyperbaric oxygen therapy downregulating H-type angiogenesis in subchondral bone of knee osteoarthritis through the PHD2/HIF-1α pathway.

Wang J, Yu W, Zhang Y, Chen B, Meng Z J Orthop Surg Res. 2025; 20(1):79.

PMID: 39844325 PMC: 11752633. DOI: 10.1186/s13018-025-05514-8.


Investigating Angiogenesis-Related Biomarkers in Osteoarthritis Patients Through Transcriptomic Profiling.

Zheng Y, Fang M, Sanan S, Meng X, Huang J, Qian Y J Inflamm Res. 2024; 17:10681-10697.

PMID: 39677287 PMC: 11638479. DOI: 10.2147/JIR.S493889.


Vascular restoration through local delivery of angiogenic factors stimulates bone regeneration in critical size defects.

Fang L, Liu Z, Wang C, Shi M, He Y, Lu A Bioact Mater. 2024; 36:580-594.

PMID: 39100886 PMC: 11295624. DOI: 10.1016/j.bioactmat.2024.07.003.


Targeting type H vessels in bone-related diseases.

Xu J, He S, Xia T, Shan Y, Wang L J Cell Mol Med. 2024; 28(4):e18123.

PMID: 38353470 PMC: 10865918. DOI: 10.1111/jcmm.18123.

References
1.
Wu H, Xu T, Chen Z, Wang Y, Li K, Chen P . Specific inhibition of FAK signaling attenuates subchondral bone deterioration and articular cartilage degeneration during osteoarthritis pathogenesis. J Cell Physiol. 2020; 235(11):8653-8666. DOI: 10.1002/jcp.29709. View

2.
Ni S, Cao Y, Liao S, Duan C, Jiang L, Hu J . Unilateral Osteotomy of Lumbar Facet Joint Induces a Mouse Model of Lumbar Facet Joint Osteoarthritis. Spine (Phila Pa 1976). 2019; 44(16):E930-E938. DOI: 10.1097/BRS.0000000000003023. View

3.
Carmeliet P . Angiogenesis in life, disease and medicine. Nature. 2005; 438(7070):932-6. DOI: 10.1038/nature04478. View

4.
Kusumbe A, Adams R . Osteoclast progenitors promote bone vascularization and osteogenesis. Nat Med. 2014; 20(11):1238-40. DOI: 10.1038/nm.3747. View

5.
Mundy G . Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer. 2002; 2(8):584-93. DOI: 10.1038/nrc867. View